首页 | 本学科首页   官方微博 | 高级检索  
检索        


CT-guided percutaneous cryoablation of central lung tumors
Authors:Errol Colak  Servet Tatl?  Paul B Shyn  Kemal Tuncal?  Stuart G Silverman
Institution:Department of Radiology (S.T. ), Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:

PURPOSE

Cryoablation has been successfully used to treat lung tumors. However, the safety and effectiveness of treating tumors adjacent to critical structures has not been fully established. We describe our experience with computed tomography (CT)-guided percutaneous cryoablation of central lung tumors and the role of ice ball monitoring.

MATERIALS AND METHODS

Eight patients with 11 malignant central lung tumors (nine metastatic, two primary; mean, 2.6 cm; range, 1.0–4.5 cm) located adjacent to mediastinal or hilar structures were treated using CT-guided cryoablation in 10 procedures. Technical success and effectiveness rates were calculated, complications were tabulated and intraprocedural imaging features of ice balls were described.

RESULTS

All procedures were technically successful; imaging after 24 hours demonstrated no residual tumor. Five tumors recurred, three of which were re-ablated successfully. A hypodense ice ball with well-defined margin was visible during the first (n=6, 55%) or second (n=11, 100%) freeze, encompassing the entire tumor in all patients, and abutting (n=7) or minimally involving (n=4) adjacent mediastinal and hilar structures. Pneumothorax developed following six procedures (60%); percutaneous treatment was applied in three of them. All patients developed pleural effusions, with one patient requiring percutaneous drainage. Transient hemoptysis occurred after six procedures (60%), but all cases improved within a week. No injury occurred to mediastinal or hilar structures.

CONCLUSION

CT-guided percutaneous cryoablation can be used to treat central lung tumors successfully. Although complications were common, they were self-limited, treatable, and not related to tumor location. Ice ball monitoring helped maximize the amount of tumor treated, while avoiding critical mediastinal and hilar structures.Malignant lung tumors represent a major cause of morbidity and mortality in developed nations (1). While surgical resection remains the treatment of choice for the local control of both non-small cell lung cancer and metastases to the lung, percutaneous image-guided ablative therapies, particularly heat-based ablation techniques such as radiofrequency (RF) ablation, have emerged as safe and effective alternatives in patients who are not surgical candidates (27). However, treatment of lung tumors using RF ablation presents technical challenges, including high electrical resistance of alveolar air, poor thermal conductivity of aerated lung, and the heat-sink effect of blood and air flow in well-perfused and aerated lung tissue (8, 9). In addition, RF ablation has a limited role in the treatment of tumors that are close to mediastinal and hilar structures (29). Since intraprocedural visualization of ablation zone margins is not possible during heat-based ablation procedures, treatment of central tumors could harm mediastinal and hilar structures, including the tracheobronchial tree. As a result, tumors close to central structures are generally not amenable to treatment using percutaneous heat-based ablation techniques (210). Also, RF ablation may interfere with conduction system of the heart and function of the pacemakers (11).A growing body of literature describes the successful use of cryoablation in the treatment of malignancies in the liver, kidneys, and soft tissues (1214). The ability to deploy multiple, individually-controlled cryoablation applicators facilitates the creation of ablation zones of desired shapes and sizes that can be tailored to the morphology of the tumor being ablated (15, 16). Cryoablation is also monitorable; ice balls can be visualized by computed tomography (CT) as a distinct ovoid area of low attenuation during the procedure. As a result, the treatment can be optimized while minimizing the risk of harming nearby critical structures (1216). Also, cryoablation may be less painful than RF ablation (17). Finally, it has been suggested that cryoablation may be better suited for the treatment of thoracic tumors adjacent to the mediastinum because it spares the architecture of collagen-containing structures relative to RF ablation and enables preservation of the integrity of the tracheobroncheal tree (18). Heat-based ablation methods may not be safe in the treatment of central lung tumors because of a possibility of bronchial disruption or perforation, which may result in bronchopleural fistula formation (19). Although cryoablation has been used to treat lung malignancies (1931), there are limited data on the safety and effectiveness of percutaneous cryoablation of central lung tumors. In this study, we describe our experience with CT-guided percutaneous cryoablation of central lung tumors and the role of ice ball monitoring.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号